Estudio del polimorfismo de receptores FcgammaIIa en pacientes chilenos con lupus eritematoso sistémico

Background: Polymorphisms of Fc receptors for IgG (FcgR) have been proposed as a genetic factor that influences susceptibility for systemic lupus erythematosus (SLE). Human FcgRIIa has 2 codominantly expressed alleles, H131 and R131, which differ at amino acid position 131 in the second extracelular domain (histidine or arginine respectively) and differ substantially in their ability to bind human IgG2. The H131 allele binds IgG2 efficiently, whereas R131 binds it poorly. Because IgG2 is a poor activator of the classical complement pathway, the H131 is essential for the disposal of IgG2 immune complexes. Aim: To determine the distribution of FcgRIIA genes in a cohort of Chilean SLE patients, with or without a history of lupus nephritis. Patients and methods: We studied 52 Chilean SLE patients fulfilling the 1982 American College of Rheumatology (ACR) criteria, 20 of whom had a history of nephritis, and 44 ethnically matched disease-free controls. FcgRIIa allotypes were genotyped by PCR. Results: No significant association was observed between the low affinity FcgRII receptor (FcgRIIa-R131) and the presence of SLE or lupus nephritis. However, genotype frequencies in SLE patients but not in controls, departed from the proportions predicted by the Hardy-Weinberg equilibrium, suggesting this locus might be related to the disease. Conclusions: Our results suggest that in Chilean patients with SLE, as well as in many other populations, the R131 allotype is not a major factor predisposing to the development of SLE or lupus nephritis (Rev Méd Chile 2003; 131: 11-18)

Saved in:
Bibliographic Details
Main Authors: Carrión A,Flavio, Figueroa E,Fernando, Martínez R,M Eugenia, Massardo V,Loreto, Pérez G,Tamara, Foster B,Carolina, Mancilla M,Cecilia, Neira Q,Oscar, Guzmán B,Leonardo, Valenzuela M,Viviana, Urrutia L,Ramón, Carmona G,Sergio, Figueroa,Maximiliano, Lubiano A,Alessandra, Wainstein G,Eduardo
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2003
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003000100002
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872003000100002
record_format ojs
spelling oai:scielo:S0034-988720030001000022003-05-13Estudio del polimorfismo de receptores FcgammaIIa en pacientes chilenos con lupus eritematoso sistémicoCarrión A,FlavioFigueroa E,FernandoMartínez R,M EugeniaMassardo V,LoretoPérez G,TamaraFoster B,CarolinaMancilla M,CeciliaNeira Q,OscarGuzmán B,LeonardoValenzuela M,VivianaUrrutia L,RamónCarmona G,SergioFigueroa,MaximilianoLubiano A,AlessandraWainstein G,Eduardo Lupus erythematosus, systemic Lupus nephritis Receptors IgG Background: Polymorphisms of Fc receptors for IgG (FcgR) have been proposed as a genetic factor that influences susceptibility for systemic lupus erythematosus (SLE). Human FcgRIIa has 2 codominantly expressed alleles, H131 and R131, which differ at amino acid position 131 in the second extracelular domain (histidine or arginine respectively) and differ substantially in their ability to bind human IgG2. The H131 allele binds IgG2 efficiently, whereas R131 binds it poorly. Because IgG2 is a poor activator of the classical complement pathway, the H131 is essential for the disposal of IgG2 immune complexes. Aim: To determine the distribution of FcgRIIA genes in a cohort of Chilean SLE patients, with or without a history of lupus nephritis. Patients and methods: We studied 52 Chilean SLE patients fulfilling the 1982 American College of Rheumatology (ACR) criteria, 20 of whom had a history of nephritis, and 44 ethnically matched disease-free controls. FcgRIIa allotypes were genotyped by PCR. Results: No significant association was observed between the low affinity FcgRII receptor (FcgRIIa-R131) and the presence of SLE or lupus nephritis. However, genotype frequencies in SLE patients but not in controls, departed from the proportions predicted by the Hardy-Weinberg equilibrium, suggesting this locus might be related to the disease. Conclusions: Our results suggest that in Chilean patients with SLE, as well as in many other populations, the R131 allotype is not a major factor predisposing to the development of SLE or lupus nephritis (Rev Méd Chile 2003; 131: 11-18)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.131 n.1 20032003-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003000100002es10.4067/S0034-98872003000100002
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Carrión A,Flavio
Figueroa E,Fernando
Martínez R,M Eugenia
Massardo V,Loreto
Pérez G,Tamara
Foster B,Carolina
Mancilla M,Cecilia
Neira Q,Oscar
Guzmán B,Leonardo
Valenzuela M,Viviana
Urrutia L,Ramón
Carmona G,Sergio
Figueroa,Maximiliano
Lubiano A,Alessandra
Wainstein G,Eduardo
spellingShingle Carrión A,Flavio
Figueroa E,Fernando
Martínez R,M Eugenia
Massardo V,Loreto
Pérez G,Tamara
Foster B,Carolina
Mancilla M,Cecilia
Neira Q,Oscar
Guzmán B,Leonardo
Valenzuela M,Viviana
Urrutia L,Ramón
Carmona G,Sergio
Figueroa,Maximiliano
Lubiano A,Alessandra
Wainstein G,Eduardo
Estudio del polimorfismo de receptores FcgammaIIa en pacientes chilenos con lupus eritematoso sistémico
author_facet Carrión A,Flavio
Figueroa E,Fernando
Martínez R,M Eugenia
Massardo V,Loreto
Pérez G,Tamara
Foster B,Carolina
Mancilla M,Cecilia
Neira Q,Oscar
Guzmán B,Leonardo
Valenzuela M,Viviana
Urrutia L,Ramón
Carmona G,Sergio
Figueroa,Maximiliano
Lubiano A,Alessandra
Wainstein G,Eduardo
author_sort Carrión A,Flavio
title Estudio del polimorfismo de receptores FcgammaIIa en pacientes chilenos con lupus eritematoso sistémico
title_short Estudio del polimorfismo de receptores FcgammaIIa en pacientes chilenos con lupus eritematoso sistémico
title_full Estudio del polimorfismo de receptores FcgammaIIa en pacientes chilenos con lupus eritematoso sistémico
title_fullStr Estudio del polimorfismo de receptores FcgammaIIa en pacientes chilenos con lupus eritematoso sistémico
title_full_unstemmed Estudio del polimorfismo de receptores FcgammaIIa en pacientes chilenos con lupus eritematoso sistémico
title_sort estudio del polimorfismo de receptores fcgammaiia en pacientes chilenos con lupus eritematoso sistémico
description Background: Polymorphisms of Fc receptors for IgG (FcgR) have been proposed as a genetic factor that influences susceptibility for systemic lupus erythematosus (SLE). Human FcgRIIa has 2 codominantly expressed alleles, H131 and R131, which differ at amino acid position 131 in the second extracelular domain (histidine or arginine respectively) and differ substantially in their ability to bind human IgG2. The H131 allele binds IgG2 efficiently, whereas R131 binds it poorly. Because IgG2 is a poor activator of the classical complement pathway, the H131 is essential for the disposal of IgG2 immune complexes. Aim: To determine the distribution of FcgRIIA genes in a cohort of Chilean SLE patients, with or without a history of lupus nephritis. Patients and methods: We studied 52 Chilean SLE patients fulfilling the 1982 American College of Rheumatology (ACR) criteria, 20 of whom had a history of nephritis, and 44 ethnically matched disease-free controls. FcgRIIa allotypes were genotyped by PCR. Results: No significant association was observed between the low affinity FcgRII receptor (FcgRIIa-R131) and the presence of SLE or lupus nephritis. However, genotype frequencies in SLE patients but not in controls, departed from the proportions predicted by the Hardy-Weinberg equilibrium, suggesting this locus might be related to the disease. Conclusions: Our results suggest that in Chilean patients with SLE, as well as in many other populations, the R131 allotype is not a major factor predisposing to the development of SLE or lupus nephritis (Rev Méd Chile 2003; 131: 11-18)
publisher Sociedad Médica de Santiago
publishDate 2003
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872003000100002
work_keys_str_mv AT carrionaflavio estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT figueroaefernando estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT martinezrmeugenia estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT massardovloreto estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT perezgtamara estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT fosterbcarolina estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT mancillamcecilia estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT neiraqoscar estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT guzmanbleonardo estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT valenzuelamviviana estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT urrutialramon estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT carmonagsergio estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT figueroamaximiliano estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT lubianoaalessandra estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
AT wainsteingeduardo estudiodelpolimorfismodereceptoresfcgammaiiaenpacienteschilenosconlupuseritematososistemico
_version_ 1755988093177954304